Detailed information for compound 945163

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 452.523 | Formula: C28H25FN4O
  • H donors: 2 H acceptors: 2 LogP: 4.38 Rotable bonds: 5
    Rule of 5 violations (Lipinski): 1
  • SMILES: CN(Cc1ccc(cc1)/C=C/c1n[nH]c2c1ccc(c2)[C@@H]1C[C@]21C(=O)Nc1c2cc(F)cc1)C
  • InChi: 1S/C28H25FN4O/c1-33(2)16-18-5-3-17(4-6-18)7-11-24-21-10-8-19(13-26(21)32-31-24)23-15-28(23)22-14-20(29)9-12-25(22)30-27(28)34/h3-14,23H,15-16H2,1-2H3,(H,30,34)(H,31,32)/b11-7+/t23-,28-/m0/s1
  • InChiKey: MXHNOOPFCLFDID-QADLAGKFSA-N  

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Homo sapiens polo-like kinase 4 Starlite/ChEMBL References

Predicted pathogen targets for this compound

By orthology
Species Potential target Known druggable target/s Ortholog Group
Echinococcus multilocularis Serine:threonine protein kinase PLK4 Get druggable targets OG5_134726 All targets in OG5_134726
Schistosoma japonicum Serine/threonine-protein kinase PLK4, putative Get druggable targets OG5_134726 All targets in OG5_134726
Echinococcus granulosus Serine:threonine protein kinase PLK4 Get druggable targets OG5_134726 All targets in OG5_134726
Schistosoma japonicum Serine/threonine-protein kinase PLK4, putative Get druggable targets OG5_134726 All targets in OG5_134726
Schistosoma mansoni kinase Get druggable targets OG5_134726 All targets in OG5_134726

By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Trichomonas vaginalis CAMK family protein kinase 0.0058 0 0.5
Trypanosoma cruzi polo-like protein kinase, putative 0.0058 0 0.5
Echinococcus granulosus Serine:threonine protein kinase PLK4 0.0135 0.5712 0.7127
Echinococcus granulosus geminin 0.0166 0.8015 1
Trichomonas vaginalis CAMK family protein kinase 0.0058 0 0.5
Entamoeba histolytica serine/threonine protein kinase, putative 0.0058 0 0.5
Echinococcus multilocularis geminin 0.0166 0.8015 1
Schistosoma mansoni hypothetical protein 0.0166 0.8015 0.8015
Trichomonas vaginalis CAMK family protein kinase 0.0058 0 0.5
Trypanosoma cruzi polo-like protein kinase, putative 0.0058 0 0.5
Loa Loa (eye worm) PLK/PLK1 protein kinase 0.0058 0 0.5
Giardia lamblia Kinase, PLK 0.0058 0 0.5
Echinococcus multilocularis Serine:threonine protein kinase PLK4 0.0135 0.5712 0.7127
Trichomonas vaginalis CAMK family protein kinase 0.0058 0 0.5
Schistosoma mansoni hypothetical protein 0.0166 0.8015 0.8015
Trichomonas vaginalis CAMK family protein kinase 0.0058 0 0.5
Leishmania major protein kinase, putative,polo-like protein kinase, putative 0.0058 0 0.5
Onchocerca volvulus Serine\/threonine kinase homolog 0.0058 0 0.5
Trichomonas vaginalis CAMK family protein kinase 0.0058 0 0.5
Trypanosoma brucei polo-like protein kinase 0.0058 0 0.5
Trichomonas vaginalis CAMK family protein kinase 0.0058 0 0.5
Brugia malayi serine/threonine-protein kinase plk-2 0.0058 0 0.5

Activities

Activity type Activity value Assay description Source Reference
GI50 (functional) = 0.1 uM Cytotoxicity against human MCF7 cells after 5 days by SRB assay ChEMBL. 24867403
IC50 (binding) = 0.79 nM Inhibition of human N-terminal GST-tagged PLK4 (1 to 391 residues) expressed in Escherichia coli incubated for 30 mins by ELISA method ChEMBL. 24867403

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.